CRBU Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.50%

Insider Buying (Last 12 Months): $49,085.47

Insider Selling (Last 12 Months): $593,242.56

Caribou Biosciences Insider Trading History Chart

Caribou Biosciences Share Price & Price History

^$9.36

▲ +0.01 (0.11%)

As of 12/7/2022 01:00 AM ET

Days: 30 | 90 | 365

Want To Catch The Next Hot Investing Trend (Look Inside?)

From Investing Trends | Ad

While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55...

And It Could Spark An Economic Boom For Investors

Caribou Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/6/2022	Ryan Fischesser	VP	Sell	10,000	$10.80	$108,000.00	110,366
8/25/2022	Steven Kanner	Insider	Sell	43,248	$11.22	$485,242.56	302,059
1/11/2022	Ryan Fischesser	VP	Buy	7,387	$4.00	$29,548.00
12/20/2021	Ryan Fischesser	VP	Buy	1,136	$2.69	$3,055.84
12/7/2021	Barbara G. McClung	Insider	Buy	6,127	$2.69	$16,481.63
10/20/2021	Barbara G. McClung	Insider	Buy	9,219	$2.69	$24,799.11
10/12/2021	Steven Kanner	Insider	Buy	114,860	$1.92	$220,531.20
10/11/2021	Ryan Fischesser	VP	Buy	1,746	$2.69	$4,696.74

Is Taiwan a Chinese Red Herring? The Real Threat to the U.S.

From Investing Trends | Ad

As tensions mount over Taiwan, China is engaging in a stealth war against the U.S. that could cripple our military production. China controls up to 90% of the critical elements needed to secure our national defense. But new mineral discoveries in America could end our dependence on China. One exploration company is well-positioned to advance U.S. national security interests.

Click here for this rare investment opportunity

SEC Filings (Institutional Ownership Changes) for Caribou Biosciences (NASDAQ:CRBU)

64.73% of Caribou Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Caribou Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2022	BNP Paribas Arbitrage SNC	83,101	$0.88M	0.0%	N/A	0.136%
11/15/2022	Alliancebernstein L.P.	29,800	$0.31M	0.0%	+18.7%	0.049%
11/15/2022	State Street Corp	2,395,470	$25.27M	0.0%	+200.3%	3.927%
11/15/2022	UBS Asset Management Americas Inc.	60,064	$0.63M	0.0%	-3.2%	0.098%
11/15/2022	Vanguard Group Inc.	2,553,428	$26.94M	0.0%	+28.2%	4.186%
11/15/2022	Long Focus Capital Management LLC	65,000	$0.69M	0.1%	-18.8%	0.107%
11/15/2022	Ensign Peak Advisors Inc	88,487	$0.93M	0.0%	+25.3%	0.145%
11/15/2022	Farallon Capital Management LLC	896,369	$9.46M	0.1%	-59.3%	1.469%
11/15/2022	Bank of New York Mellon Corp	181,471	$1.91M	0.0%	+23.3%	0.297%
11/15/2022	Bellevue Group AG	66,300	$0.70M	0.0%	-5.7%	0.109%
11/15/2022	BlackRock Inc.	4,478,190	$47.24M	0.0%	+10.6%	7.341%
11/15/2022	Commonwealth Equity Services LLC	22,375	$0.24M	0.0%	+37.8%	0.037%
11/14/2022	Elmwood Wealth Management Inc.	2,364,240	$24.94M	12.4%	N/A	3.876%
11/14/2022	LMR Partners LLP	15,207	$0.16M	0.0%	-84.0%	0.025%
11/14/2022	Penserra Capital Management LLC	23,987	$0.25M	0.0%	+354.3%	0.039%
11/14/2022	Nuveen Asset Management LLC	223,407	$2.36M	0.0%	-12.3%	0.366%
11/14/2022	Pictet Asset Management SA	3,290,898	$34.72M	0.1%	+22.4%	5.395%
11/10/2022	Credit Suisse AG	34,996	$0.37M	0.0%	+7.2%	0.058%
11/10/2022	Tower Research Capital LLC TRC	13,557	$0.14M	0.0%	+341.9%	0.022%
11/10/2022	UBS Group AG	48,902	$0.52M	0.0%	+253.2%	0.080%
11/8/2022	International Biotechnology Trust PLC	257,892	$2.72M	0.9%	+18,614.9%	0.424%
11/8/2022	New York State Common Retirement Fund	61,798	$0.65M	0.0%	+40.2%	0.102%
11/7/2022	Virtu Financial LLC	20,067	$0.21M	0.0%	+7.3%	0.033%
11/3/2022	Teacher Retirement System of Texas	15,941	$0.17M	0.0%	N/A	0.026%
11/3/2022	Barclays PLC	83,401	$0.88M	0.0%	+2,978.7%	0.137%
11/3/2022	Regents of The University of California	90,652	$0.96M	0.2%	-50.0%	0.149%
11/1/2022	Tekla Capital Management LLC	567,147	$5.98M	0.2%	-18.9%	0.932%
10/31/2022	SG Americas Securities LLC	23,440	$0.25M	0.0%	+52.7%	0.039%
10/27/2022	Assenagon Asset Management S.A.	799,491	$8.44M	0.0%	-28.0%	1.314%
10/18/2022	Bailard Inc.	19,700	$0.21M	0.0%	-16.2%	0.032%
10/14/2022	Green Alpha Advisors LLC	69,376	$0.73M	0.6%	-72.5%	0.114%
8/30/2022	Verition Fund Management LLC	47,489	$0.26M	0.0%	N/A	0.078%
8/22/2022	Legal & General Group Plc	16,473	$89K	0.0%	+46.6%	0.027%
8/22/2022	ExodusPoint Capital Management LP	54,344	$0.30M	0.0%	N/A	0.089%
8/18/2022	Goldman Sachs Group Inc.	140,318	$0.76M	0.0%	-49.8%	0.231%
8/16/2022	International Biotechnology Trust PLC	1,378	$0.26M	2.7%	N/A	0.002%
8/15/2022	Occudo Quantitative Strategies LP	18,520	$0.10M	0.0%	-25.8%	0.030%
8/15/2022	State Street Corp	797,600	$4.33M	0.0%	+7.3%	1.311%
8/15/2022	Millennium Management LLC	24,916	$0.14M	0.0%	-90.4%	0.041%
8/15/2022	UBS Asset Management Americas Inc.	62,018	$0.34M	0.0%	+104.7%	0.102%
8/15/2022	Stansberry Asset Management LLC	69,338	$0.38M	0.1%	-25.3%	0.114%
8/13/2022	Virtu Financial LLC	18,695	$0.10M	0.0%	N/A	0.031%
8/13/2022	Zurcher Kantonalbank Zurich Cantonalbank	10,485	$57K	0.0%	N/A	0.017%
8/13/2022	Renaissance Technologies LLC	239,000	$1.30M	0.0%	+64.7%	0.394%
8/12/2022	Northern Trust Corp	450,080	$2.44M	0.0%	+11.5%	0.741%
8/12/2022	Virtus ETF Advisers LLC	20,215	$0.11M	0.0%	+115.2%	0.033%
8/12/2022	Credit Suisse AG	32,636	$0.18M	0.0%	+74.4%	0.054%
8/12/2022	FMR LLC	1,524,335	$8.28M	0.0%	-24.3%	2.505%
8/12/2022	Franchise Capital Ltd	123,436	$0.67M	0.2%	N/A	0.203%
8/12/2022	Franklin Resources Inc.	14,480	$79K	0.0%	-32.5%	0.024%
8/12/2022	Rhumbline Advisers	76,338	$0.42M	0.0%	+57.9%	0.126%
8/11/2022	UBS Group AG	13,847	$75K	0.0%	-11.5%	0.023%
8/11/2022	JPMorgan Chase & Co.	509,568	$2.77M	0.0%	-1.2%	0.839%
8/9/2022	Swiss National Bank	114,400	$0.62M	0.0%	+100.7%	0.188%
8/9/2022	Pictet Asset Management SA	2,689,227	$14.60M	0.0%	+0.2%	4.430%
8/3/2022	Janney Montgomery Scott LLC	18,793	$0.11M	0.0%	N/A	0.031%
8/3/2022	DekaBank Deutsche Girozentrale	24,200	$0.14M	0.0%	N/A	0.040%
8/2/2022	Pinnacle Associates Ltd.	12,903	$70K	0.0%	N/A	0.021%
8/1/2022	Pinnacle Wealth Management Advisory Group LLC	12,903	$70K	0.0%	N/A	0.021%
8/1/2022	ProShare Advisors LLC	10,793	$59K	0.0%	-31.5%	0.018%
7/29/2022	SG Americas Securities LLC	15,347	$83K	0.0%	N/A	0.025%
7/28/2022	Arizona State Retirement System	13,152	$71K	0.0%	N/A	0.022%
7/27/2022	Bailard Inc.	23,500	$0.13M	0.0%	N/A	0.039%
7/27/2022	Assenagon Asset Management S.A.	1,109,929	$6.03M	0.0%	N/A	1.828%
7/27/2022	Nelson Capital Management LLC	85,020	$0.46M	0.1%	+31.1%	0.140%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	218,665	$1.19M	0.0%	+44.7%	0.360%
7/19/2022	Commonwealth Equity Services LLC	16,240	$88K	0.0%	N/A	0.027%
7/8/2022	Green Alpha Advisors LLC	252,272	$1.37M	0.3%	+407.9%	0.416%
6/30/2022	Amalgamated Bank	4,851	$45K	0.0%	N/A	0.008%
6/7/2022	Bank of America Corp DE	19,576	$0.18M	0.0%	-78.3%	0.032%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	151,165	$1.39M	0.0%	-15.5%	0.249%
5/17/2022	Stansberry Asset Management LLC	92,789	$0.85M	0.1%	+37.7%	0.153%
5/17/2022	Ensign Peak Advisors Inc	70,608	$0.65M	0.0%	+9.0%	0.116%
5/17/2022	Farallon Capital Management LLC	2,657,052	$24.39M	0.1%	-10.3%	4.377%
5/16/2022	California State Teachers Retirement System	42,132	$0.39M	0.0%	+33.8%	0.069%
5/16/2022	Goldman Sachs Group Inc.	279,458	$2.57M	0.0%	+780.9%	0.460%
5/16/2022	State Street Corp	743,022	$6.82M	0.0%	+79.9%	1.224%
5/16/2022	Vident Investment Advisory LLC	72,366	$0.66M	0.0%	+20.0%	0.119%
5/16/2022	Invesco Ltd.	12,113	$0.11M	0.0%	N/A	0.020%
5/16/2022	UBS Group AG	15,641	$0.14M	0.0%	-12.8%	0.026%
5/16/2022	Granahan Investment Management LLC	286,672	$2.63M	0.1%	+249.1%	0.472%
5/13/2022	Ameritas Investment Partners Inc.	3,945	$36K	0.0%	+168.4%	0.006%
5/13/2022	Renaissance Technologies LLC	145,100	$1.33M	0.0%	+51.2%	0.239%
5/13/2022	Northern Trust Corp	403,770	$3.71M	0.0%	+119.3%	0.665%
5/13/2022	Charles Schwab Investment Management Inc.	214,545	$1.97M	0.0%	+50.5%	0.353%
5/13/2022	Penserra Capital Management LLC	6,668	$61K	0.0%	N/A	0.011%
5/13/2022	American International Group Inc.	25,253	$0.23M	0.0%	+134.3%	0.042%
5/13/2022	Vanguard Group Inc.	2,001,554	$18.38M	0.0%	+118.9%	3.297%
5/12/2022	BlackRock Inc.	3,319,182	$30.47M	0.0%	+88.3%	5.514%
5/12/2022	Rhumbline Advisers	48,358	$0.44M	0.0%	+145.2%	0.080%
5/12/2022	Metropolitan Life Insurance Co NY	3,632	$33K	0.0%	-36.2%	0.006%
5/12/2022	MetLife Investment Management LLC	31,003	$0.29M	0.0%	+311.7%	0.052%
5/12/2022	Monashee Investment Management LLC	470,000	$4.32M	1.2%	-6.8%	0.781%
5/12/2022	Artal Group S.A.	105,347	$0.97M	0.0%	-74.0%	0.175%
5/12/2022	Citigroup Inc.	22,489	$0.21M	0.0%	-26.3%	0.037%
5/11/2022	Bank of New York Mellon Corp	141,262	$1.30M	0.0%	+108.2%	0.235%
5/11/2022	JPMorgan Chase & Co.	515,758	$4.74M	0.0%	+2,754.9%	0.857%
5/11/2022	GSA Capital Partners LLP	25,021	$0.23M	0.0%	N/A	0.042%
5/10/2022	ProShare Advisors LLC	15,766	$0.15M	0.0%	+22.1%	0.026%
5/9/2022	Swiss National Bank	57,000	$0.52M	0.0%	+8.0%	0.095%

Data available starting January 2016

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.

Today's Range

Now: $9.36

$9.12

$9.48

50 Day Range

MA: $9.52

$8.34

$11.01

52 Week Range

Now: $9.36

$4.89

$19.32

Volume

525,181 shs

Average Volume

678,985 shs

Market Capitalization

$570.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

Who are the company insiders with the largest holdings of Caribou Biosciences?: Caribou Biosciences' top insider shareholders include:
Steven Kanner (Insider)
Ryan Fischesser (VP)
Barbara G Mcclung (Insider)
Learn More about top insider investors at Caribou Biosciences.
Who are the major institutional investors of Caribou Biosciences?: Caribou Biosciences' top institutional shareholders include:
BlackRock Inc. — 7.34%
Pictet Asset Management SA — 5.39%
Vanguard Group Inc. — 4.19%
State Street Corp — 3.93%
Elmwood Wealth Management Inc. — 3.88%
Farallon Capital Management LLC — 1.47%
Learn More about top institutional investors of Caribou Biosciences stock.
Which institutional investors are selling Caribou Biosciences stock?: In the last quarter, CRBU stock was sold by these institutional investors:
Farallon Capital Management LLC
Assenagon Asset Management S.A.
Green Alpha Advisors LLC
Tekla Capital Management LLC
Regents of The University of California
LMR Partners LLP
Nuveen Asset Management LLC
Long Focus Capital Management LLC
Within the previous year, company insiders that have sold Caribou Biosciences company stock include:
Steven Kanner (Insider)
Ryan Fischesser (VP)
Learn More investors selling Caribou Biosciences stock.
Which institutional investors are buying Caribou Biosciences stock?: During the previous quarter, CRBU stock was purchased by institutional investors including:
Elmwood Wealth Management Inc.
State Street Corp
Pictet Asset Management SA
Vanguard Group Inc.
BlackRock Inc.
International Biotechnology Trust PLC
BNP Paribas Arbitrage SNC
Barclays PLC
Within the last year, these company insiders have bought Caribou Biosciences stock:
Steven Kanner (Insider)
Ryan Fischesser (VP)
Barbara G Mcclung (Insider)
Learn More investors buying Caribou Biosciences stock.